TY - JOUR
T1 - Preferential involvement of Na+/Ca2+ exchanger type-1 in the brain damage caused by transient focal cerebral ischemia in mice
AU - Morimoto, Nobutaka
AU - Kita, Satomi
AU - Shimazawa, Masamitsu
AU - Namimatsu, Hiroko
AU - Tsuruma, Kazuhiro
AU - Hayakawa, Kazuhide
AU - Mishima, Kenichi
AU - Egashira, Nobuaki
AU - Iyoda, Takuya
AU - Horie, Ichiro
AU - Gotoh, Yusuke
AU - Iwasaki, Katsunori
AU - Fujiwara, Michihiro
AU - Matsuda, Toshio
AU - Baba, Akemichi
AU - Komuro, Issei
AU - Horie, Kyoji
AU - Takeda, Junji
AU - Iwamoto, Takahiro
AU - Hara, Hideaki
N1 - Funding Information:
This work was supported by Grant-in-Aids for Scientific Research on Innovative Areas (S.K.) from MEXT and for Scientific Research (S.K., T.I., H.H.) from JSPS , and a grant from the Vehicle Racing Commemorative Foundation (T.I).
PY - 2012/12/14
Y1 - 2012/12/14
N2 - The Na+/Ca2+ exchanger (NCX), an ion-transporter located in the plasma membrane of neuronal cells, contributes to intracellular Ca2+ homeostasis. Within the brain, three isoforms (NCX1, NCX2, and NCX3) are widely distributed. However, it is not clear to what extent these isoforms are involved in ischemic brain damage in mammals. We therefore used genetically altered mice and isoform-selective NCX inhibitors in a model of transient focal ischemia to investigate the role of each NCX isoform in ischemic brain damage. NCX isoform-mutant mice (NCX1+/-, NCX2+/-, and NCX3+/-) and wild-type mice were subjected to 90min of middle cerebral artery occlusion (MCAO) followed by 24h of reperfusion. One of three NCX inhibitors [SN-6, KB-R7943, or SEA0400 (3 or 10mgkg-1, i.p.)] was administered to ddY mice at 30min before more prolonged (4-h) MCAO followed by 24h of reperfusion. After transient MCAO reperfusion, the cerebral infarcts in NCX1+/- mice, but not those in NCX2+/- or NCX3+/- mice, were significantly smaller than those in wild-type mice. SN-6 and SEA0400, which are more selective for the NCX1 isoform, significantly reduced the infarct volume at 10mg/kg. In contrast, KB-R7943, which is more selective for NCX3, did not. These results suggest that the NCX1 isoform may act preferentially (vs. the NCX2 and NCX3 isoforms) to exacerbate the cerebral damage caused by ischemic insult in mice, and that NCX1-selective inhibitors warrant investigation as a potential therapeutic agents for stroke.
AB - The Na+/Ca2+ exchanger (NCX), an ion-transporter located in the plasma membrane of neuronal cells, contributes to intracellular Ca2+ homeostasis. Within the brain, three isoforms (NCX1, NCX2, and NCX3) are widely distributed. However, it is not clear to what extent these isoforms are involved in ischemic brain damage in mammals. We therefore used genetically altered mice and isoform-selective NCX inhibitors in a model of transient focal ischemia to investigate the role of each NCX isoform in ischemic brain damage. NCX isoform-mutant mice (NCX1+/-, NCX2+/-, and NCX3+/-) and wild-type mice were subjected to 90min of middle cerebral artery occlusion (MCAO) followed by 24h of reperfusion. One of three NCX inhibitors [SN-6, KB-R7943, or SEA0400 (3 or 10mgkg-1, i.p.)] was administered to ddY mice at 30min before more prolonged (4-h) MCAO followed by 24h of reperfusion. After transient MCAO reperfusion, the cerebral infarcts in NCX1+/- mice, but not those in NCX2+/- or NCX3+/- mice, were significantly smaller than those in wild-type mice. SN-6 and SEA0400, which are more selective for the NCX1 isoform, significantly reduced the infarct volume at 10mg/kg. In contrast, KB-R7943, which is more selective for NCX3, did not. These results suggest that the NCX1 isoform may act preferentially (vs. the NCX2 and NCX3 isoforms) to exacerbate the cerebral damage caused by ischemic insult in mice, and that NCX1-selective inhibitors warrant investigation as a potential therapeutic agents for stroke.
UR - http://www.scopus.com/inward/record.url?scp=84870708982&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870708982&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2012.10.114
DO - 10.1016/j.bbrc.2012.10.114
M3 - Article
C2 - 23137542
AN - SCOPUS:84870708982
SN - 0006-291X
VL - 429
SP - 186
EP - 190
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3-4
ER -